DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
BörsenkürzelDRIO
Name des UnternehmensDarioHealth Corp
IPO-datumMar 08, 2013
CEORaphael (Erez)
Anzahl der mitarbeiter196
WertpapierartOrdinary Share
GeschäftsjahresendeMar 08
Addresse322 W 57Th St. #33B
StadtNEW YORK
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl10019
Telefon16466654667
Websitehttps://shop.mydario.com/
BörsenkürzelDRIO
IPO-datumMar 08, 2013
CEORaphael (Erez)
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten